Livechain Inc (LICH)

[Plinker]

"... -They are in, or about to enter, Phase 3 of a very important therapeutic (VB 1953)..."

I think Venkat bought this ticker because he thinks this new acne topical treatment has the potential to be very sucessful. If I remember correctly, the Vyome website states that Phase 2 was successfully completed in June of 2020 (almost 2 years ago). I fail to find any evidence that Phase 3 testing has begun. (Sucessful Phase 3 required before FDA approval).

If anyone contacts Venkat or their CFO (Craig Tooman?), the best question is to ask them is the status of the Phase 3 trial. Successful Phase 3 trial is the lynchpin of this ticker.